Works matching IS 15228517 AND DT 2020 AND VI 22 AND IP 4
Results: 17
Letter regarding "Cognitive outcomes in meningioma patients undergoing surgery: individual changes over time and predictors of late cognitive functioning".
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 4, p. 580, doi. 10.1093/neuonc/noz247
- By:
- Publication type:
- Article
Exclusion of patients with brain metastases from cancer clinical trials.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 4, p. 577, doi. 10.1093/neuonc/noz246
- By:
- Publication type:
- Article
HDAC inhibition induces expression of scaffolding proteins critical for tumor progression in pediatric glioma: focus on EBP50 and IRSp53.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 4, p. 550, doi. 10.1093/neuonc/noz215
- By:
- Publication type:
- Article
Deep learning–based detection and segmentation-assisted management of brain metastases.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 4, p. 505, doi. 10.1093/neuonc/noz234
- By:
- Publication type:
- Article
Toward a standard pathological and molecular characterization of recurrent glioma in adults: a Response Assessment in Neuro-Oncology effort.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 4, p. 450, doi. 10.1093/neuonc/noz233
- By:
- Publication type:
- Article
Synergistic activity of mTORC1/2 kinase and MEK inhibitors suppresses pediatric low-grade glioma tumorigenicity and vascularity.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 4, p. 563, doi. 10.1093/neuonc/noz230
- By:
- Publication type:
- Article
Extensive brainstem infiltration, not mass effect, is a common feature of end-stage cerebral glioblastomas.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 4, p. 470, doi. 10.1093/neuonc/noz216
- By:
- Publication type:
- Article
Connexin43 peptide, TAT-Cx43<sub>266–283</sub>, selectively targets glioma cells, impairs malignant growth, and enhances survival in mouse models in vivo.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 4, p. 493, doi. 10.1093/neuonc/noz243
- By:
- Publication type:
- Article
Metabolic reprogramming associated with aggressiveness occurs in the G-CIMP-high molecular subtypes of IDH1<sup>mut</sup> lower grade gliomas.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 4, p. 480, doi. 10.1093/neuonc/noz207
- By:
- Publication type:
- Article
Betacellulin drives therapy resistance in glioblastoma.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 4, p. 457, doi. 10.1093/neuonc/noz206
- By:
- Publication type:
- Article
Survival of diffuse astrocytic glioma, IDH1/2 wildtype, with molecular features of glioblastoma, WHO grade IV: a confirmation of the cIMPACT-NOW criteria.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 4, p. 515, doi. 10.1093/neuonc/noz200
- By:
- Publication type:
- Article
Highlights from the literature.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 4, p. 446, doi. 10.1093/neuonc/noaa049
- By:
- Publication type:
- Article
The Society for Neuro-Oncology: 20/20 vision for the future.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 4, p. 435, doi. 10.1093/neuonc/noaa043
- By:
- Publication type:
- Article
To add IT chemotherapy, or not to add, that is the question.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 4, p. 442, doi. 10.1093/neuonc/noaa040
- By:
- Publication type:
- Article
Dual blockade of STAT3 and EGFR: a key to unlock drug resistance in glioblastoma?
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 4, p. 440, doi. 10.1093/neuonc/noaa039
- By:
- Publication type:
- Article
Understanding innate immune response in glioblastoma in search of a way forward.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 4, p. 444, doi. 10.1093/neuonc/noaa038
- By:
- Publication type:
- Article
Analogous survival for patients with glioblastoma diagnosed by either histopathological or molecular features.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 4, p. 437, doi. 10.1093/neuonc/noaa009
- By:
- Publication type:
- Article